Amgen - 35 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1984 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Amgen as of February 15, 2019 is 188.34.
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 193.7356 191.9000 203.8800 184.2300 188.3400 -3.25%
2018 186.7270 173.2196 208.8900 163.6984 194.6700 14.39%
2017 164.9338 143.5165 185.6703 143.5165 170.1858 22.25%
2016 146.7136 146.8776 166.0810 127.8754 139.2128 -7.55%
2015 145.2652 145.3729 162.1937 122.0285 150.5788 3.97%
2014 118.1857 103.2939 156.0561 99.3175 144.8274 42.32%
2013 91.9700 78.0738 105.4349 71.8822 101.7641 34.80%
2012 66.3335 55.0954 78.9671 54.7946 75.4903 36.80%
2011 47.7931 47.2460 55.6368 41.0542 55.1813 18.18%
2010 47.4171 49.0876 52.0003 42.8318 46.6931 -2.95%
2009 46.7061 50.1717 54.7815 38.3666 48.1135 -2.04%
2008 43.4963 39.6339 56.0402 33.9950 49.1171 24.35%
2007 49.2655 58.1750 64.5113 39.4978 39.4978 -32.02%
2006 60.0836 68.3472 68.3472 54.3647 58.0985 -13.38%
2005 59.4929 54.6709 73.2886 48.6493 67.0714 22.93%
2004 50.0956 53.0294 56.3294 44.8220 54.5604 3.82%
2003 52.2564 41.9473 60.8456 41.5730 52.5531 27.82%
2002 42.0084 47.9689 53.1400 26.4254 41.1138 -14.35%
2001 52.9992 53.4802 63.0995 43.8099 48.0029 -11.73%
2000 55.6843 53.5312 66.3400 43.6398 54.3817 6.46%
1999 31.5620 22.8363 55.1812 22.2749 51.0818 129.90%
1998 14.2089 11.4692 22.3047 10.0212 22.2196 93.05%
1997 11.8501 11.6157 14.5395 9.7809 11.5096 -0.46%
1996 12.4172 12.3854 13.8206 10.9502 11.5625 -8.42%
1995 8.6667 6.1927 12.6256 6.0066 12.6256 101.29%
1994 5.1475 5.2221 6.3128 3.7592 6.2724 19.19%
1993 4.4704 7.5078 7.5216 3.3488 5.2625 -29.91%
1992 6.8562 7.9468 8.2658 5.3156 7.5078 -6.77%
1991 4.8030 2.2591 8.0532 2.0465 8.0532 265.06%
1990 1.3999 0.9125 2.2457 0.7929 2.2060 154.09%
1989 0.7770 0.5670 1.0631 0.5647 0.8682 45.18%
1988 0.5418 0.5714 0.6334 0.4563 0.5980 8.87%
1987 0.5712 0.4187 0.7885 0.2879 0.5493 40.92%
1986 0.3584 0.2236 0.5029 0.2215 0.3898 62.96%
1985 0.1359 0.0842 0.2569 0.0819 0.2392 169.98%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $116.167B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $85.858B 10.77
Biogen (BIIB) United States $63.873B 12.38
Celgene (CELG) United States $63.569B 11.78
Vertex Pharmaceuticals (VRTX) United States $47.481B 63.60
Regeneron Pharmaceuticals (REGN) United States $45.346B 21.06
Illumina (ILMN) United States $42.993B 51.13
Alexion Pharmaceuticals (ALXN) United States $28.142B 17.44
Incyte (INCY) United States $17.752B 166.84
BioMarin Pharmaceutical (BMRN) United States $16.643B 0.00
Seattle Genetics (SGEN) United States $11.010B 0.00
Exact Sciences (EXAS) United States $10.830B 0.00
Sarepta Therapeutics (SRPT) United States $9.013B 0.00
QIAGEN (QGEN) Netherlands $8.716B 28.50
Alnylam Pharmaceuticals (ALNY) United States $8.401B 0.00
BeiGene (BGNE) Cayman Islands $8.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.121B 47.98
Exelixis (EXEL) United States $6.667B 15.59
Moderna (MRNA) United States $6.467B 0.00
Amarin (AMRN) Ireland $5.603B 0.00
Galapagos (GLPG) Belgium $5.280B 0.00
Alkermes (ALKS) Ireland $5.050B 0.00
Array BioPharma (ARRY) United States $4.809B 0.00
Guardant Health (GH) United States $4.191B 0.00
Horizon Pharma Public (HZNP) Ireland $3.844B 15.81
Allogene Therapeutics (ALLO) United States $3.783B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.759B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.424B 0.00
Emergent Biosolutions (EBS) United States $3.312B 27.90
Intercept Pharmaceuticals (ICPT) United States $3.298B 0.00
Blueprint Medicines (BPMC) United States $3.276B 0.00
Ascendis Pharma (ASND) Denmark $2.965B 0.00
Genomic Health (GHDX) United States $2.945B 99.42
Ultragenyx Pharmaceutical (RARE) United States $2.805B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.743B 0.00
China Biologic Products (CBPO) China $2.688B 19.13
Immunomedics (IMMU) United States $2.668B 0.00
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Repligen (RGEN) United States $2.580B 80.57
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.559B 0.00
Mirati Therapeutics (MRTX) United States $2.504B 0.00
Akcea Therapeutics (AKCA) United States $2.399B 0.00
Halozyme Therapeutics (HALO) United States $2.391B 53.35
Arena Pharmaceuticals (ARNA) United States $2.379B 0.00
Myriad Genetics (MYGN) United States $2.265B 23.07
Amicus Therapeutics (FOLD) United States $2.122B 0.00
Insmed (INSM) United States $2.012B 0.00
Acceleron Pharma (XLRN) United States $1.929B 0.00
Denali Therapeutics (DNLI) United States $1.924B 0.00
Spark Therapeutics (ONCE) United States $1.910B 0.00
AnaptysBio (ANAB) United States $1.851B 0.00
Atara Biotherapeutics (ATRA) United States $1.800B 0.00
Medicines (MDCO) United States $1.773B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.770B 0.00
MyoKardia (MYOK) United States $1.691B 0.00
REGENXBIO (RGNX) United States $1.666B 22.34
NeoGenomics (NEO) United States $1.629B 134.08
CRISPR Therapeutics AG (CRSP) Switzerland $1.605B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.600B 0.00
Myovant Sciences (MYOV) United Kingdom $1.522B 0.00
Innoviva (INVA) United States $1.488B 4.10
Allakos (ALLK) United States $1.485B 0.00
Aimmune Therapeutics (AIMT) United States $1.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.360B 0.00
Clovis Oncology (CLVS) United States $1.343B 0.00
UniQure (QURE) Netherlands $1.341B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.237B 0.00
Lion Biotechnologies (IOVA) United States $1.217B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.210B 0.00
Cambrex (CBM) United States $1.201B 12.97
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.182B 0.00
Codexis (CDXS) United States $1.177B 0.00
Rubius Therapeutics (RUBY) United States $1.083B 0.00
WAVE Life Sciences (WVE) Singapore $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.055B 42.81
Deciphera Pharmaceuticals (DCPH) United States $1.053B 0.00
Puma Biotechnology (PBYI) United States $1.035B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.022B 0.00
Audentes Therapeutics (BOLD) United States $1.021B 0.00
Epizyme (EPZM) United States $0.987B 0.00
Coherus BioSciences (CHRS) United States $0.965B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.964B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.955B 0.00
Editas Medicine (EDIT) United States $0.950B 0.00
Fate Therapeutics (FATE) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.919B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Novavax (NVAX) United States $0.842B 0.00
Athenex (ATNX) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 0.00
CytomX Therapeutics (CTMX) United States $0.832B 0.00
Apellis Pharmaceuticals (APLS) United States $0.799B 0.00
G1 THERAPEUTICS (GTHX) United States $0.779B 0.00
Intra-Cellular Therapies (ITCI) United States $0.745B 0.00
Heska (HSKA) United States $0.741B 60.67
Acorda Therapeutics (ACOR) United States $0.740B 9.60
Y-mAbs Therapeutics (YMAB) United States $0.732B 0.00
InflaRx (IFRX) Germany $0.729B 0.00
Arvinas (ARVN) United States $0.727B 0.00
Cellectis (CLLS) France $0.711B 0.00
Principia Biopharma (PRNB) United States $0.698B 0.00
ANI Pharmaceuticals (ANIP) United States $0.698B 13.34
Dicerna Pharmaceuticals (DRNA) United States $0.672B 0.00
Dynavax Technologies (DVAX) United States $0.661B 0.00
Revance Therapeutics (RVNC) United States $0.659B 0.00
RA PHARMCTL INC (RARX) United States $0.659B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.655B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.647B 0.00
Twist Bioscience (TWST) United States $0.628B 0.00
Intellia Therapeutics (NTLA) United States $0.603B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.564B 0.00
UROGEN PHARMA (URGN) Israel $0.557B 0.00
Anika Therapeutics (ANIK) United States $0.555B 22.98
Kura Oncology (KURA) United States $0.551B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.550B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.542B 0.00
Osiris Therapeutics (OSIR) United States $0.525B 0.00
Eidos Therapeutics (EIDX) United States $0.517B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
Zymeworks (ZYME) Canada $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.478B 0.00
Synthorx (THOR) United States $0.477B 0.00
UNITY Biotechnology (UBX) $0.476B 0.00
PDL BioPharma (PDLI) United States $0.472B 7.69
DBV Technologies (DBVT) France $0.467B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.457B 0.00
Zealand Pharma (ZEAL) Denmark $0.452B 4.98
Clementia Pharmaceuticals (CMTA) Canada $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.436B 0.00
Agenus (AGEN) United States $0.425B 0.00
Replimune (REPL) United States $0.424B 0.00
Senesco Technologies (ELOX) United States $0.419B 0.00
Cytokineticsorporated (CYTK) United States $0.417B 0.00
Scholar Rock Holding (SRRK) United States $0.416B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.414B 0.00
Five Prime Therapeutics (FPRX) United States $0.408B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
OSMOTICA PHARM (OSMT) United States $0.394B 0.00
Kezar Life Sciences (KZR) United States $0.388B 0.00
Sinovac Biotech (SVA) China $0.379B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.366B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.360B 0.00
Kindred Biosciences (KIN) United States $0.355B 0.00
Stemline Therapeutics (STML) United States $0.353B 0.00
Inovio Pharmaceuticals (INO) United States $0.352B 0.00
AVROBIO (AVRO) United States $0.352B 0.00
Cellular Biomedicine (CBMG) United States $0.350B 0.00
MeiraGTx Holdings (MGTX) United States $0.349B 0.00
Gritstone Oncology (GRTS) United States $0.327B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.326B 0.00
Krystal Biotech (KRYS) United States $0.321B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
BioDelivery Sciences (BDSI) United States $0.318B 0.00
XBiotech (XBIT) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.312B 0.00
Albireo Pharma (ALBO) United States $0.309B 0.00
Evelo Biosciences (EVLO) United States $0.305B 0.00
Gamida Cell (GMDA) Israel $0.304B 0.00
Enochian BioSciences (ENOB) United States $0.299B 0.00
Constellation Pharmaceuticals (CNST) United States $0.292B 0.00
Aduro Biotech (ADRO) United States $0.292B 0.00
MediciNova (MNOV) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Magenta Therapeutics (MGTA) United States $0.279B 0.00
Sorrento Therapeutics (SRNE) United States $0.276B 0.00
Solid Biosciences (SLDB) United States $0.275B 0.00
Axsome Therapeutics (AXSM) United States $0.273B 0.00
Merus (MRUS) Netherlands $0.272B 0.00
Intec Pharma (NTEC) Israel $0.265B 0.00
Geron (GERN) United States $0.265B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.258B 0.00
Liquidia Technologies (LQDA) United States $0.257B 0.00
AC Immune SA (ACIU) Switzerland $0.257B 0.00
Kadmon Holdings (KDMN) United States $0.256B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.249B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.231B 0.00
Celcuity (CELC) United States $0.229B 0.00
Synlogic (SYBX) United States $0.228B 0.00
Verastem (VSTM) United States $0.227B 0.00
Kamada (KMDA) Israel $0.227B 10.26
ResTORbio (TORC) United States $0.224B 0.00
MannKind (MNKD) United States $0.222B 0.00
Sutro Biopharma (STRO) United States $0.221B 0.00
Adverum Biotechnologies (ADVM) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.220B 0.00
Syros Pharmaceuticals (SYRS) United States $0.219B 0.00
TOCAGEN INC (TOCA) United States $0.216B 0.00
Athersys (ATHX) United States $0.213B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.205B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.202B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
Compugen (CGEN) Israel $0.192B 0.00
Aptinyx (APTX) United States $0.191B 0.00
CorMedix Inc (CRMD) United States $0.187B 0.00
Cerecor (CERC) United States $0.184B 0.00
Protagonist Therapeutics (PTGX) United States $0.179B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.177B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.168B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Palatin Technologies (PTN) United States $0.159B 78.29
Menlo Therapeutics (MNLO) United States $0.155B 0.00
BioXcel Therapeutics (BTAI) United States $0.155B 0.00
Proteostasis Therapeutics (PTI) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.150B 0.00
Mersana Therapeutics (MRSN) United States $0.147B 0.00
OvaScience (MLND) United States $0.147B 0.00
BioTime (BTX) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.144B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.141B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.139B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.128B 0.00
Trevena (TRVN) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Cue Biopharma (CUE) United States $0.126B 0.00
Pfenex (PFNX) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.123B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.120B 0.00
Mustang Bio (MBIO) United States $0.118B 0.00
Pluristem Therapeutics (PSTI) Israel $0.117B 0.00
XOMA (XOMA) United States $0.117B 0.00
Eton Pharmaceuticals (ETON) United States $0.115B 0.00
Equillium (EQ) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
VolitionRX (VNRX) Singapore $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Chiasma (CHMA) United States $0.092B 0.00
Neothetics (EVFM) United States $0.091B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
NantKwest (NK) United States $0.087B 0.00
Cel-Sci (CVM) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.080B 88.67
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.076B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.074B 0.00
Aptose Biosciences (APTO) Canada $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Cidara Therapeutics (CDTX) United States $0.069B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.63
SESEN BIO, INC (SESN) United States $0.061B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Ophthotech (OPHT) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
OVID THERAPEUTC (OVID) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
VIVUS (VVUS) United States $0.055B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
Alcobra (ARCT) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.61
VistaGen Therapeutics (VTGN) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.050B 0.00
Asterias Biotherapeutics (AST) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Selecta Biosciences (SELB) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Motif Bio Plc (MTFB) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Arsanis (ASNS) United States $0.040B 0.00
Caladrius Biosciences (CLBS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.032B 0.00
Galena Biopharma (SLS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.030B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.030B 4.81
IMMURON LTD (IMRN) Australia $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Vical (VICL) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
IBio (IBIO) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Soligenix (SNGX) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 6.93
Genetic Technologies (GENE) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
Hemispherx BioPharma (HEB) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00